Mesa Laboratories MLAB

NASDAQ MLAB
$123.74 -0.17 (-0.14%)
As of: Sep 10, 2026 · 12:50 PM EDT
Key Stats
Market Cap700.90 Mn
P/E199.18
P/S2.81
Div. Yield0.01
Total Debt (Qtr)160.13 Mn
Revenue Growth (1y) (Qtr)1.00
Add ratio to table…

About

Mesa Laboratories, Inc. is a global provider of life sciences tools and critical quality control solutions for the pharmaceutical healthcare and medical device industries. The company designs manufactures and sells products that help customers ensure product integrity increase patient and worker safety and improve quality of life worldwide. Mesa Laboratories, Inc. generates revenue from the sale of products including consumables and hardware and from the provision of…

Read more ↓
Sector: Healthcare Sector rationale Mesa Laboratories designs and manufactures life sciences tools, genetic analysis tools (Clinical Genomics), and protein analysis systems (Biopharmaceutical Development) sold to pharmaceutical companies, hospitals, and clinical research labs. These activities fall squarely within the Healthcare sector's 'Life Sciences Tools', 'Medical Devices', and 'Contract Research' industries. Industries: Life Sciences Tools Life Sciences Tools Primary Mesa Laboratories designs and manufactures life sciences tools, including the MassARRAY system for genomic testing and Gyrolab systems for protein analysis and peptide synthesis. These products, along with their associated chips, panels, and reagents, are sold to biopharma R&D teams, academic laboratories, and clinical research labs. Medical Supplies Medical Supplies Secondary The Sterilization and Disinfection Control segment manufactures and sells biological and chemical indicators, inoculated carriers, and cleaning consumables used to assess sterilization effectiveness in healthcare and pharmaceutical settings. Diagnostic Equipment Diagnostic Equipment Secondary The company sells clinical diagnostic tools and consumables, such as the MassARRAY system and related reagent solutions, used by reference pathology labs and clinical research labs for inherited disease and oncology testing. Classified using BQ-MICS CIK: 0000724004

Geographical Breakdown of Revenue (2026)

Timing of Transfer of Good or Service Breakdown of Revenue (2026)

Peer group

Peer Comparison

Companies in the Life Sciences Tools
S.No. Ticker Company matchMarket CapP/EP/STotal Debt (Qtr)
1 TMO Thermo Fisher Scientific Inc. primary224.07 Bn31.834.8445.65 Bn
2 DHR Danaher Corp /De/ primary142.65 Bn35.755.6827.97 Bn
3 A Agilent Technologies, Inc. primary40.38 Bn28.045.484.25 Bn
4 ILMN Illumina, Inc. primary30.75 Bn37.286.841.99 Bn
5 RVTY Revvity, Inc. primary13.66 Bn57.504.693.21 Bn
6 TECH BIO-TECHNE Corp primary11.27 Bn61.989.280.20 Bn
7 BIO Bio-Rad Laboratories, Inc. primary9.99 Bn44.923.861.60 Bn
8 RGEN Repligen Corp primary9.21 Bn149.1611.730.55 Bn